The current standard for diagnosis of infection with SARS-CoV-2 is rRT-PCR test. However many studies proving that routine laboratory examinations reveal a number of abnormalities in COVID-19 patients. Mortality among patients with severe COVID-19 could be significantly reduced by early identification and timely treatment of critical cases. Some inflammatory (procalcitonin, CRP), hematological (lymphocyte, Thrombocytes), and biochemical (ASAT, ALAT, CK-MB, LDH, D-dimer, γ-GT) biomarkers are significantly associated with severe COVID-19. These biomarkers might help in prognostic risk stratification of patients with COVID-19. In some countries, biomarkers such as CRP, PCT, lymphopenia, and IL-6 and IL-10 are already being used to aid diagnosis or to provide early evidence of more severe disease progression.
We manufacture products that deliver tests results you can trust.
We supply high-quality in-vitro diagnostic solutions all over the world.
We comply with the legal requirements.
We care about productivity to provide our customers with competitive products.
We want to meet our customers' expectations.
The specification was based on data determined on selected analyzers. We recommend that all users should refer to the instruction for use (IFU) and instruments’ user or service manuals before proceeding.
Order this product
To order this product, please contact your Area Sales Manager for details. If you have any questions, click the button below and fill out the form. We will contact you as soon as possible.